Article
Drug firm Indivior plans to move primary listing to US in snub to London
Rating:
0.0
Views:
26
Likes:
1
Library:
1
Move is latest in number of delistings and IPO snubs to London Stock Exchange, including Tui
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value